Robert A. Copeland, President of Research and CSO at Epizyme, Inc. (EPZM), sold 5,000 shares at $17.44 ($87K) on 2017-05-02, disclosed to the SEC on 2017-05-03.
Open-market sale of $87k EPZM by President of Research and CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |
| EPZM | SELL | 2016-01-04 | $130K | — | Filing → |